Sensory outcomes after targeted nipple-areola complex reinnervation: A systematic review and meta-analysis
Journal of Plastic, Reconstructive & Aesthetic Surgery · 2026-06 · 117 · 235-246
DOI: 10.1016/j.bjps.2026.04.020 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2026-06. Verfasst von Carson Gundlach und 7 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Medicine, New York, NY, USA. Electronic address: cwg4001@med.cornell.edu. Hauptthemen laut MEDLINE: Nipples, Mammaplasty. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Targeted nipple-areola complex (NAC) reinnervation (TNR) aims to restore nipple sensation after gender-affirming (GA) chest surgery and oncologic mastectomy; however, the outcomes have not been systematically synthesized. METHODS We performed a PRISMA systematic review (PROSPERO CRD420250653209; March 20, 2025) of the PubMed, Embase, Scopus, Web of Science, and ClinicalTrials.gov databases. Two independent reviewers performed screening and data extraction. Risk of bias was assessed using ROBINS-I. Random-effects meta-analysis pooled postoperative Semmes-Weinstein (SW) monofilament thresholds as mean differences (TNR minus control) at the longest comparable follow-up. Included studies were observational (prospective and retrospective cohorts and case series). RESULTS Ten studies were included (4 GA; 6 oncologic/prophylactic), representing 281 unique patients. The meta-analysis included three comparative cohorts. TNR was associated with improved nipple sensation (-1.40 SW units; 95% CI -1.95, -0.86; I² 58.1%). In a GA subgroup (2 studies), the pooled effect was similar (-1.54; 95% CI -2.28, -0.80; I² 74.9%). Single-arm studies reported recovery of protective sensation after TNR. In the largest comparative cohort with multidimensional quantitative sensory testing, NAC cold detection differed by 11.1 °C (95% CI 7.6, 14.6), and NAC 2-point discrimination was present in 40% of TNR patients versus 0% of controls. In a nipple erection substudy, nipple erection was reported in 73% (16/22) of TNR nipples versus 39% (7/18) of controls. CONCLUSIONS TNR was associated with improved postoperative NAC sensory outcomes, but the available evidence was observational and subject to moderate-to-serious risk of bias. Larger prospective multicenter studies with standardized sensory testing, longer follow-up, and validated patient-reported outcomes are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Weill Cornell Medicine, New York, NY, USA. Electronic address: cwg4001@med.cornell.edu.
- Weill Cornell Medicine, New York, NY, USA.
- Cornell University, Ithaca, NY, USA.
- Samuel J. Wood Library and C.V. Starr Biomedical Information Center, Weill Cornell Medical College, New York, NY, USA.
- Division of Plastic Surgery, New York-Presbyterian/Weill Cornell Medicine, New York, NY, USA.
Zitieren
APA
Gundlach, C., Rahman, R., Martinez, M., McVeigh, A. B., Park-Lee, H., Jewell, S., Qin, N., & Otterburn, D. M. (2026). Sensory outcomes after targeted nipple-areola complex reinnervation: A systematic review and meta-analysis. Journal of Plastic, Reconstructive & Aesthetic Surgery, 117, 235-246. https://doi.org/10.1016/j.bjps.2026.04.020
Vancouver
Gundlach C, Rahman R, Martinez M, McVeigh AB, Park-Lee H, Jewell S, et al. Sensory outcomes after targeted nipple-areola complex reinnervation: A systematic review and meta-analysis. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2026;117:235-246. doi:10.1016/j.bjps.2026.04.020
BibTeX
@article{Gundlach2026,
author = {Gundlach, Carson and Rahman, Ramia and Martinez, Maria and McVeigh, Annie B and Park-Lee, Hanelle and Jewell, Sarah and Qin, Nancy and Otterburn, David M},
title = {Sensory outcomes after targeted nipple-areola complex reinnervation: A systematic review and meta-analysis},
journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
year = {2026},
volume = {117},
pages = {235--246},
doi = {10.1016/j.bjps.2026.04.020}
}
EUVIMED